| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |